Theravance Biopharma TBPH Change in Other Assets
Change in Other Assets at other companies
Other financials
Where this comes from
Reported directly by Theravance Biopharma in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInOtherOperatingAssets.
The official record: Theravance Biopharma’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Theravance Biopharma's change in other assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Theravance Biopharma's change in other assets?
- Theravance Biopharma (TBPH) reported change in other assets of -$1.03M in Q1 2026.
- How has Theravance Biopharma's change in other assets changed year-over-year?
- Theravance Biopharma's change in other assets decreased by 210.6% year-over-year, from -$330K to -$1.03M.
- What is the long-term trend for Theravance Biopharma's change in other assets?
- Over 2 years (2021 to 2023), Theravance Biopharma's change in other assets has grown at a 10.7% compound annual growth rate (CAGR), from $1.01M to $1.23M.
- What does change in other assets mean?
- Change in miscellaneous assets affecting operating cash flow.